Abstract
Lung cancer is the leading cause of cancer deaths in the United States and worldwide with a survival rate of only approximately 10–20%. Lung cancer incidence is tied closely to tobacco smoking, particularly cigarette smoking, and varies by country with the history of tobacco use. Although cigarette smoking is the greatest risk factor for lung cancer, only 10% of tobacco smokers develop lung cancer, and other factors must be involved. Other agents are believed to increase lung cancer risk but less often than cigarette smoking.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Siegal RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2016;66(1):7–30.
Bray F, Ren JS, Masuyer E, Ferlay J. Estimates of global cancer prevalence for 27 sites in the adult population in 2008. Int J Cancer. 2013;132(5):1133–45.
Allemani C, Weir HK, Carreira H, et al. Global surveillance of cancer survival 1995–2009: analysis of individual data for 25,676,887 patients from 279 population based registries in 67 countries (CONCORD-2). Lancet. 2015;385(9972):977–101.
Colditz GA, Sellers TA, Trapido E. Epidemiology—identifying the causes and preventability of cancer? Nat Rev Cancer. 2006;6(1):75–83.
Torre LA, Siegel RL, Ward EM, Jemal A. International variation in lung cancer mortality rates and trends among women. Cancer Epidemiol Biomark Prev. 2014;23(6):1025–36.
Bosetti C, Malvezzi M, Rosso T, et al. Lung cancer mortality in European women: trends and predictions. Lung Cancer. 2012;78(3):171–8.
Youlden DR, Cramb SM, Baade PD. The international epidemiology of lung cancer: geographical distribution and secular trends. J Thorac Oncol. 2008;3(8):819–31.
Lam WK, White NW, Chan-Yeung MM. Lung cancer epidemiology and risk factors in Asia and Africa. Int J Tuberc Lung Dis. 2004;8(9):1045–57.
Eriksen M, Mackay J, Ross H. The Tobacco Atlas. 4th ed. Atlanta: American Cancer Society; 2012.
Adcock IM, Caramori G, Barnes PJ. Chronic obstructive pulmonary disease and lung cancer: new molecular insights. Respiration. 2011;81(4):265–84.
Alberg AJ, Semet JM. Epidemiology of lung cancer. Chest. 2003;123(supplement):21S–49S.
Cagle PT, Allen TC. Genetic susceptibility to lung cancer. In: Zander D, Popper HH, Jaigrdar J, Haque A, Cagle PT, Barrios R, editors. Molecular pathology of lung diseases. New York: Springer; 2008.
Cagle PT. Carcinoma of the lung. In: Churg AM, Myers JL, Tazelaar HD, Wright JL, editors. Pathology of the lung. 3rd ed. New York: Thieme Medical Publishers; 2005. p. 413–79.
Hrubec Z, McLaughlin JK. Former cigarette smoking and mortality among US veterans: a 26-year follow-up, 1954–1980. In: Burns DM, Garfinkel L, Samet JM, editors. Changes in cigarette-related disease risks and their implications for prevention and control. Bethesda: US Government Printing Office; 1997. p. 501–30.
US Department of Health and Human Services: The health benefits of smoking cessation. US Department of Health and Human Services, Public Health Service, Centers for Disease Control, Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health. DHHS Publication No (CDC) 89–8416, 1990.
El Ghissassi F, Baan R, Straif K, et al. A review of human carcinogens–part D: radiation. Lancet Oncol. 2009;10(8):751–2.
Danaei G, Vander Hoorn S, Lopez AD, Murray CJ, Ezzati M. Causes of cancer in the world: comparative risk assessment of nine behavioural and environmental risk factors. Lancet. 2005;366(9499):1784–93.
American Cancer Society. Global cancer facts and figures. 3rd ed. Atlanta: American Cancer Society; 2015.
Herr C, Greulich T, Koczulla RA, Meyer S, Zakharkina T, Branscheidt M, Eschmann R, Bals R. The role of vitamin D in pulmonary disease: COPD, asthma, infection, and cancer. Respir Res. 2011;12:31.
Kirk GD, Merlo CA. Lung HIV study. HIV infection in the etiology of lung cancer: confounding, causality, and consequences. Proc Am Thorac Soc. 2011;8(3):326–32.
Sholl LM, Nishino M. Adenocarcinoma. In: Cagle PR, Allen TC, editors. Lung and pleural pathology. China: McGraw-Hill Education; 2016. p. 41–72.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG
About this chapter
Cite this chapter
Miller, R.A., Cagle, P.T. (2018). Lung Cancer Epidemiology and Demographics. In: Cagle, P., et al. Precision Molecular Pathology of Lung Cancer. Molecular Pathology Library. Springer, Cham. https://doi.org/10.1007/978-3-319-62941-4_2
Download citation
DOI: https://doi.org/10.1007/978-3-319-62941-4_2
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-62940-7
Online ISBN: 978-3-319-62941-4
eBook Packages: MedicineMedicine (R0)